AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications. The latest tool in genome science – CRISPR/Cas9 is a simple and efficient genome editing tool which allows for specific genome disruption and replacement resulting in high specificity and low cell toxicity. AMSBIO CRISPR Complete kits are […]
A consistent and reproducible model for drug development, toxicity testing and disease modelling applications Cambridge, UK – Axol Bioscience, the human cell culture specialists, provide highly validated primary cells and iPSC-derived cells together with optimised media and growth supplements, launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of […]
Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State […]
This strategic acquisition strengthens the Group’s offer for the life sciences market Paris Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), leading French group in the fields of specialty in vitro medical diagnostics and life sciences, announces that it acquired Dendritics, a French company based in Lyon, specializing in antibody development and production. This acquisition was paid in cash, with […]
Sunnyvale – Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and […]
New data shows Inscripta’s MADzymes edit in mammalian cells Boulder, Colo. – Inscripta, a leading gene-editing technology company, today announced two significant milestones. First, the USPTO granted Inscripta its first patent covering systems using MAD7, the company’s first free CRISPR enzyme, as well as patent coverage for systems using another MADzyme, MAD2. Second, Inscripta released new […]
Ness Ziona, Israel – Buckwheat researchers from Japan now have access to the most accurate genome available, thanks to NRGene. The project was done with Dr. Yasuo Yasui, a renowned buckwheat scientist, in cooperation with GeneBay, NRGene’s partner in Japan. The results were presented yesterday at the annual meeting of the Society for Molecular Biology […]
Porvair is a leading developer and manufacturer of sintered porous materials that offer optimum solutions in a wide range of applications. Developed for the Bioscience market – BioVyon™ is a high-performance porous polymeric material manufactured to the highest cleanliness standards. This unique material, produced from high-density polyethylene resin using a proprietary process that can be […]
FORT COLLINS, Colo. — KromaTiD, Inc. announced today that it has joined the National Institute of Standards and Technology Genome Editing Consortium, a newly launched public/private partnership (https://www.nist.gov/programs-projects/nist-genome-editing-consortium). The Consortium supports the emerging gene editing market and regulatory agency needs for standardized measurements of gene edits, editing by-products and the risks of utilizing genome editing technologies in research, […]
Ensures validity and reliability of data from cell culture-based research MANASSAS, Va. — ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, today announced the availability of its new PCR-based service to detect mycoplasma contamination in cell cultures. This growing service portfolio is […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
